21 markets that work genuinely differently.

The most sophisticated buyers, the most expensive talent, and competitors who all read the same growth playbook. Differentiation here is genuinely harder than anywhere else.

New York has the highest media costs and the densest competition in the country. Efficiency isn't an optimization here — it's the entire game.

LA consumer brands live and die on paid social, and paid social is now won by creative throughput. This is the market where our production system matters most.

Manufacturing, logistics, distribution, and professional services. Long cycles, technical buyers, and small addressable markets where precision beats volume.

Austin companies tend to be capital-efficient by necessity. That's an advantage — it forces the sequential channel discipline that better-funded companies skip.

Seattle's buyers are disproportionately engineers. Documentation-grade content beats campaign-grade content here, consistently and by a wide margin.

Healthcare, biotech, and education dominate here — and all three carry constraints that make standard marketing tracking a genuine compliance risk.

Outdoor and lifestyle brands here sell to customers who will test the product in the field and post about it. Overclaiming gets caught faster than anywhere else.

Miami businesses routinely sell into both US and Latin American markets. Those markets have different payment behaviour, different CPMs, and different conversion patterns entirely.

Canadian companies compete against US-funded rivals for a domestic market a fraction of the size. Efficiency isn't a preference here — it's structural.

Atlanta processes a large share of US card transactions and moves a large share of its freight. Both are unglamorous, high-consideration B2B categories with long cycles.

Most UK and EU tracking setups we audit are technically non-compliant and quietly losing 30–40% of measurable conversions to consent rejection.

Nashville sells care delivery and the businesses around it. That's a different marketing problem from selling clinical software, and it gets conflated constantly.

Dublin runs EMEA for a lot of companies. Managing thirty markets from one team is a structural problem, not a translation one.

Brands selling through retail and direct at the same time face a conflict most marketing advice ignores entirely.

The Wasatch Front runs on recurring revenue models. That makes churn, not acquisition cost, the number that decides whether growth works.

In a market dominated by hospital systems and universities, the constraint is almost never the idea. It is the eleven weeks and six signatures between the idea and the launch.

Portland's customers are unusually well informed and unusually unforgiving. A claim you cannot substantiate is not just a regulatory risk here — it is a brand risk with a long memory.

Phoenix has a population that swells and contracts on a schedule. Flat monthly budgets in a market with a seasonal audience overspend into an empty room for half the year.

Most Vancouver businesses sell into the US, and most of them model unit economics in a single currency. That one simplification hides where the margin actually goes.

Dallas sells to a boardroom that relocated here for the tax line. Fort Worth sells to a plant manager who has always been here. Running one campaign at both is how budget gets wasted in this market.